Anna Wald Selected Research

Herpes Simplex

12/2017	Performance of Commercial Enzyme-Linked Immunoassays for Diagnosis of Herpes Simplex Virus-1 and Herpes Simplex Virus-2 Infection in a Clinical Setting.
2/2016	Mathematical modeling of herpes simplex virus-2 suppression with pritelivir predicts trial outcomes.
1/2013	Short communication: T cell activation in HIV-1/herpes simplex virus-2-coinfected Kenyan women receiving valacyclovir.
1/2012	Efficacy results of a trial of a herpes simplex vaccine.
1/2012	Effects of valacyclovir on markers of disease progression in postpartum women co-infected with HIV-1 and herpes simplex virus-2.
11/2011	Detailed analysis of mucosal herpes simplex virus-2 replication kinetics with and without antiviral therapy.
6/2010	APOE genotype is associated with oral herpetic lesions but not genital or oral herpes simplex virus shedding.
5/2010	Population level impact of an imperfect prophylactic vaccine for herpes simplex virus-2.
10/2003	Immunodominance among herpes simplex virus-specific CD8 T cells expressing a tissue-specific homing receptor.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Anna Wald Research Topics

Disease

77	Infections 04/2024 - 04/2002
39	Herpes Genitalis (Genital Herpes) 03/2023 - 04/2002
20	COVID-19 12/2023 - 06/2020
11	Ulcer 05/2016 - 06/2004
9	Herpes Simplex 12/2017 - 10/2003
8	Neoplasms (Cancer) 01/2022 - 04/2002
7	Virus Diseases (Viral Diseases) 01/2016 - 10/2003
7	Human Influenza (Influenza) 09/2013 - 05/2010
5	Sexually Transmitted Diseases (Sexually Transmitted Disease) 07/2023 - 12/2005
5	Disease Progression 01/2013 - 05/2008
4	Reinfection 01/2021 - 08/2016
4	Inflammation (Inflammations) 10/2017 - 09/2003
4	Viremia 09/2013 - 01/2009
3	HIV Infections (HIV Infection) 07/2023 - 01/2009
3	Tuberculosis (Tuberculoses) 01/2022 - 01/2013
3	Malaria 12/2020 - 09/2013
3	Respiratory Insufficiency (Respiratory Failure) 03/2011 - 03/2004
2	Convalescence 10/2022 - 08/2022
2	Neonatal herpes 03/2022 - 12/2007
2	Hypersensitivity (Allergy) 10/2020 - 06/2020
2	Fever (Fevers) 06/2020 - 01/2013
2	Thrombocytopenia (Thrombopenia) 06/2020 - 01/2020
2	Neutropenia 06/2020 - 04/2002
2	Hematologic Neoplasms (Hematological Malignancy) 01/2020 - 01/2019
2	Hemorrhage 01/2020 - 01/2019
2	Bacteremia 01/2019 - 01/2013
2	Herpes Zoster 02/2016 - 10/2015
2	Vaccinia 09/2015 - 10/2003
2	Bacterial Vaginosis 07/2015 - 02/2015
2	Coinfection 05/2010 - 08/2006
2	Kaposi Sarcoma (Kaposi's Sarcoma) 05/2008 - 10/2002
1	secondary Syphilis 02/2024
1	Exanthema (Rash) 02/2024
1	Central Nervous System Diseases (CNS Diseases) 03/2022
1	Substance-Related Disorders (Drug Abuse) 01/2022
1	Uterine Cervical Neoplasms (Cancer of the Cervix) 01/2022
1	Parasitemia 12/2020

Drug/Important Bio-Agent (IBA)

29	VaccinesIBA 05/2023 - 04/2003
23	Acyclovir (Aciclovir)FDA LinkGeneric 03/2022 - 04/2002
21	Antiviral Agents (Antivirals)IBA 01/2021 - 04/2002
18	DNA (Deoxyribonucleic Acid)IBA 01/2020 - 03/2004
13	Valacyclovir (Valtrex)FDA LinkGeneric 03/2023 - 10/2003
12	AntigensIBA 02/2024 - 03/2011
12	AntibodiesIBA 03/2021 - 10/2002
7	RNA (Ribonucleic Acid)IBA 12/2017 - 02/2007
6	Neutralizing AntibodiesIBA 01/2022 - 11/2014
6	EnzymesIBA 12/2017 - 10/2003
6	Glycoproteins (Glycoprotein)IBA 11/2014 - 04/2003
5	Hydroxychloroquine (Plaquenil)FDA LinkGeneric 12/2022 - 06/2020
5	Proteins (Proteins, Gene)FDA Link 01/2021 - 10/2015
4	Immunoglobulin G (IgG)IBA 04/2024 - 10/2020
4	NucleoproteinsIBA 03/2021 - 10/2020
4	ImmunosorbentsIBA 12/2017 - 08/2004
4	pritelivirIBA 12/2016 - 01/2014
4	Famciclovir (Famvir)FDA LinkGeneric 11/2007 - 04/2006
3	T-Cell Antigen Receptors (T-Cell Receptor)IBA 12/2023 - 03/2021
3	Messenger RNA (mRNA)IBA 12/2023 - 10/2022
3	N-(2-cyanoethylene)urea (BA 1)IBA 05/2023 - 07/2022
3	Viral RNAIBA 01/2022 - 05/2010
3	Antimalarials (Antimalarial Agents)IBA 12/2020 - 09/2013
3	Biomarkers (Surrogate Marker)IBA 11/2020 - 12/2004
3	Hemoglobins (Hemoglobin)IBA 01/2020 - 01/2013
3	EpitopesIBA 03/2016 - 09/2010
2	Ascorbic Acid (Vitamin C)FDA LinkGeneric 03/2021 - 06/2020
2	SARS-CoV-2 spike proteinIBA 01/2021 - 10/2020
2	Chloroquine (Aralen)FDA LinkGeneric 12/2020 - 06/2020
2	Anti-Bacterial Agents (Antibiotics)IBA 10/2020 - 07/2012
2	InterferonsIBA 10/2017 - 07/2010
2	NucleosidesIBA 12/2016 - 08/2006
2	DNA Primase (Primase)IBA 01/2016 - 01/2014
2	Subunit VaccinesIBA 01/2012 - 03/2011
2	peramivirIBA 03/2011 - 05/2010
2	DNA-Directed DNA Polymerase (Polymerases, DNA)IBA 01/2011 - 08/2005
2	Peptides (Polypeptides)IBA 05/2008 - 10/2003
1	bioplexIBA 04/2024
1	Recombinant ProteinsIBA 05/2023
1	2019-nCoV Vaccine mRNA-1273IBA 05/2023
1	BNT162 VaccineIBA 05/2023
1	Combined VaccinesIBA 05/2023
1	COVID-19 VaccinesIBA 05/2023
1	Biological FactorsIBA 01/2023
1	mRNA VaccinesIBA 07/2022
1	Isoniazid (Ftivazide)FDA LinkGeneric 01/2022
1	Folic Acid (Vitamin M)FDA LinkGeneric 03/2021
1	Azithromycin (Zithromax)FDA LinkGeneric 03/2021
1	B-Lymphocyte Epitopes (B-Cell Epitope)IBA 01/2021

Therapy/Procedure

37	Therapeutics 01/2022 - 04/2002
6	Condoms (Condom) 01/2021 - 04/2002
4	Transplantation 01/2022 - 04/2002
4	Art Therapy 11/2018 - 10/2012
3	Aftercare (After-Treatment) 02/2024 - 01/2016
3	Drug Therapy (Chemotherapy) 01/2019 - 03/2004
2	Donor Selection 01/2021 - 10/2020
2	Blood Transfusion (Blood Transfusions) 01/2020 - 10/2018
2	Male Circumcision 02/2015 - 02/2012
2	Artificial Respiration (Mechanical Ventilation) 03/2011 - 05/2010
2	Highly Active Antiretroviral Therapy (HAART) 05/2008 - 08/2004
2	Hematopoietic Stem Cell Transplantation 07/2004 - 04/2002
1	Contraception (Birth Control) 07/2023
1	Cell- and Tissue-Based Therapy (Cell Therapy) 01/2022